FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2232912109> ?p ?o ?g. }

• W2232912109 endingPage "1652" @default.
• W2232912109 startingPage "1645" @default.
• W2232912109 abstract "We sought to evaluate clinical outcomes of patients with diabetes mellitus in the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial, overall and by treatment arm.In the ACUITY trial, 13,819 patients with moderate- or high-risk acute coronary syndromes (ACS) were randomized to heparin (unfractionated or enoxaparin) plus glycoprotein IIb/IIIa inhibition (GPI), bivalirudin plus GPI, or bivalirudin monotherapy. Compared with heparin plus GPI, bivalirudin monotherapy resulted in similar protection from ischemic events with less major bleeding. Whether these results apply to patients with diabetes is unknown.We evaluated the impact of diabetes on 30-day net adverse clinical outcomes (composite ischemia [death, myocardial infarction, or unplanned ischemic revascularization] or major bleeding), overall and by antithrombotic strategy.Diabetes was present in 3,852 randomized patients (27.9%). Compared with nondiabetic patients, diabetic patients had higher 30-day rates of net adverse clinical outcomes (12.9% vs. 10.6%; p < 0.001), composite ischemia (8.7% vs. 7.2%; p = 0.003), and major bleeding (5.7% vs. 4.2%; p < 0.001). Among diabetic patients, compared with heparin plus GPI, bivalirudin plus GPI resulted in similar rates of net adverse clinical outcomes (14.0% vs. 13.8%; p = 0.89), while bivalirudin monotherapy resulted in a similar rate of composite ischemia (7.9% vs. 8.9%; p = 0.39) and less major bleeding (3.7% vs. 7.1%; p < 0.001), yielding fewer net adverse clinical outcomes (10.9% vs. 13.8%; p = 0.02).Diabetic patients with ACS managed invasively have higher rates of composite ischemia and major bleeding. Compared with treatment with heparin plus GPI, bivalirudin monotherapy provides similar protection from ischemic events with less major bleeding, resulting in a significant reduction in net adverse clinical outcomes." @default.
• W2232912109 created "2016-06-24" @default.
• W2232912109 creator A5011617429 @default.
• W2232912109 creator A5014072369 @default.
• W2232912109 creator A5016139987 @default.
• W2232912109 creator A5045761776 @default.
• W2232912109 creator A5046629853 @default.
• W2232912109 creator A5048154042 @default.
• W2232912109 creator A5050863307 @default.
• W2232912109 creator A5083980876 @default.
• W2232912109 date "2008-04-01" @default.
• W2232912109 modified "2023-10-02" @default.
• W2232912109 title "Safety and Efficacy of Bivalirudin Monotherapy in Patients With Diabetes Mellitus and Acute Coronary Syndromes" @default.
• W2232912109 cites W1488980985 @default.
• W2232912109 cites W1573872903 @default.
• W2232912109 cites W1979838917 @default.
• W2232912109 cites W1993966022 @default.
• W2232912109 cites W2005966755 @default.
• W2232912109 cites W2016642467 @default.
• W2232912109 cites W2035369939 @default.
• W2232912109 cites W2043998212 @default.
• W2232912109 cites W2045713748 @default.
• W2232912109 cites W2059136191 @default.
• W2232912109 cites W2059601021 @default.
• W2232912109 cites W2074504036 @default.
• W2232912109 cites W2079337704 @default.
• W2232912109 cites W2080318130 @default.
• W2232912109 cites W2081799397 @default.
• W2232912109 cites W2082011014 @default.
• W2232912109 cites W2093117607 @default.
• W2232912109 cites W2099409915 @default.
• W2232912109 cites W2121251309 @default.
• W2232912109 cites W2144931422 @default.
• W2232912109 cites W2147642245 @default.
• W2232912109 cites W2154783291 @default.
• W2232912109 cites W2164435543 @default.
• W2232912109 cites W2165256339 @default.
• W2232912109 cites W2170181314 @default.
• W2232912109 cites W2207113963 @default.
• W2232912109 cites W3022148767 @default.
• W2232912109 cites W4205805944 @default.
• W2232912109 doi "https://doi.org/10.1016/j.jacc.2007.11.081" @default.
• W2232912109 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18436116" @default.
• W2232912109 hasPublicationYear "2008" @default.
• W2232912109 type Work @default.
• W2232912109 sameAs 2232912109 @default.
• W2232912109 citedByCount "69" @default.
• W2232912109 countsByYear W22329121092012 @default.
• W2232912109 countsByYear W22329121092013 @default.
• W2232912109 countsByYear W22329121092014 @default.
• W2232912109 countsByYear W22329121092015 @default.
• W2232912109 countsByYear W22329121092016 @default.
• W2232912109 countsByYear W22329121092017 @default.
• W2232912109 countsByYear W22329121092018 @default.
• W2232912109 countsByYear W22329121092019 @default.
• W2232912109 countsByYear W22329121092020 @default.
• W2232912109 countsByYear W22329121092021 @default.
• W2232912109 countsByYear W22329121092022 @default.
• W2232912109 countsByYear W22329121092023 @default.
• W2232912109 crossrefType "journal-article" @default.
• W2232912109 hasAuthorship W2232912109A5011617429 @default.
• W2232912109 hasAuthorship W2232912109A5014072369 @default.
• W2232912109 hasAuthorship W2232912109A5016139987 @default.
• W2232912109 hasAuthorship W2232912109A5045761776 @default.
• W2232912109 hasAuthorship W2232912109A5046629853 @default.
• W2232912109 hasAuthorship W2232912109A5048154042 @default.
• W2232912109 hasAuthorship W2232912109A5050863307 @default.
• W2232912109 hasAuthorship W2232912109A5083980876 @default.
• W2232912109 hasBestOaLocation W22329121091 @default.
• W2232912109 hasConcept C126322002 @default.
• W2232912109 hasConcept C134018914 @default.
• W2232912109 hasConcept C164705383 @default.
• W2232912109 hasConcept C168563851 @default.
• W2232912109 hasConcept C197934379 @default.
• W2232912109 hasConcept C2777557582 @default.
• W2232912109 hasConcept C2777565915 @default.
• W2232912109 hasConcept C2777698277 @default.
• W2232912109 hasConcept C2779464278 @default.
• W2232912109 hasConcept C2780400711 @default.
• W2232912109 hasConcept C500558357 @default.
• W2232912109 hasConcept C555293320 @default.
• W2232912109 hasConcept C71924100 @default.
• W2232912109 hasConceptScore W2232912109C126322002 @default.
• W2232912109 hasConceptScore W2232912109C134018914 @default.
• W2232912109 hasConceptScore W2232912109C164705383 @default.
• W2232912109 hasConceptScore W2232912109C168563851 @default.
• W2232912109 hasConceptScore W2232912109C197934379 @default.
• W2232912109 hasConceptScore W2232912109C2777557582 @default.
• W2232912109 hasConceptScore W2232912109C2777565915 @default.
• W2232912109 hasConceptScore W2232912109C2777698277 @default.
• W2232912109 hasConceptScore W2232912109C2779464278 @default.
• W2232912109 hasConceptScore W2232912109C2780400711 @default.
• W2232912109 hasConceptScore W2232912109C500558357 @default.
• W2232912109 hasConceptScore W2232912109C555293320 @default.
• W2232912109 hasConceptScore W2232912109C71924100 @default.
• W2232912109 hasIssue "17" @default.
• W2232912109 hasLocation W22329121091 @default.
• W2232912109 hasLocation W22329121092 @default.

• next